UNICA IRIS Institutional Research Information System

FANTINI, MASSIMO CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 63.727
NA - Nord America 5.628
AS - Asia 2.480
SA - Sud America 804
AF - Africa 60
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 72.722
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 62.837
US - Stati Uniti d'America 5.538
SG - Singapore 1.197
BR - Brasile 652
CN - Cina 629
SE - Svezia 328
VN - Vietnam 283
DE - Germania 134
FI - Finlandia 115
GB - Regno Unito 108
HK - Hong Kong 90
AR - Argentina 56
IN - India 52
FR - Francia 47
CA - Canada 41
MX - Messico 34
BD - Bangladesh 33
EC - Ecuador 33
KR - Corea 29
NL - Olanda 25
AT - Austria 23
TR - Turchia 21
ZA - Sudafrica 21
CO - Colombia 20
IQ - Iraq 20
PL - Polonia 20
AU - Australia 19
ID - Indonesia 18
JP - Giappone 16
PK - Pakistan 14
MA - Marocco 13
PY - Paraguay 13
UA - Ucraina 13
UZ - Uzbekistan 13
CZ - Repubblica Ceca 12
ES - Italia 11
EG - Egitto 9
IL - Israele 8
KZ - Kazakistan 8
PE - Perù 7
RU - Federazione Russa 7
SA - Arabia Saudita 7
VE - Venezuela 7
CH - Svizzera 6
CL - Cile 6
KE - Kenya 6
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
NP - Nepal 5
UY - Uruguay 5
AZ - Azerbaigian 4
BG - Bulgaria 4
DK - Danimarca 4
GR - Grecia 4
HU - Ungheria 4
IE - Irlanda 4
LT - Lituania 4
MY - Malesia 4
SK - Slovacchia (Repubblica Slovacca) 4
XK - ???statistics.table.value.countryCode.XK??? 4
GT - Guatemala 3
IR - Iran 3
JO - Giordania 3
OM - Oman 3
PH - Filippine 3
TN - Tunisia 3
BE - Belgio 2
BH - Bahrain 2
BO - Bolivia 2
DZ - Algeria 2
GY - Guiana 2
IS - Islanda 2
JM - Giamaica 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
HN - Honduras 1
KH - Cambogia 1
KW - Kuwait 1
MD - Moldavia 1
ML - Mali 1
NG - Nigeria 1
NI - Nicaragua 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UG - Uganda 1
YE - Yemen 1
Totale 72.722
Salva come PNG Salva come JPEG
Città #
Cagliari 59.092
Uta 3.531
Fairfield 883
Ashburn 578
Singapore 441
Woodbridge 403
Seattle 380
Dallas 339
Houston 325
Cambridge 318
Boardman 310
Wilmington 297
Nyköping 253
Beijing 125
Santa Clara 124
Los Angeles 123
Ann Arbor 108
Boston 98
Ho Chi Minh City 91
Helsinki 88
New York 87
Jacksonville 79
Hefei 67
Hong Kong 63
Buffalo 59
Shanghai 54
São Paulo 53
Hanoi 48
Chandler 46
Rome 42
San Diego 42
Dearborn 37
Munich 36
Dong Ket 32
Redwood City 31
Hangzhou 28
Seoul 28
Rio de Janeiro 26
Chicago 25
London 25
Atlanta 21
The Dalles 21
Frankfurt am Main 20
Nuremberg 20
Milan 19
Montreal 19
Mountain View 17
Melbourne 16
Belo Horizonte 15
Denver 15
Nanjing 15
Turku 14
Vienna 14
Warsaw 14
Brasília 13
Brooklyn 13
Curitiba 13
Düsseldorf 13
Guayaquil 13
Phoenix 13
Redondo Beach 13
Amsterdam 12
Lappeenranta 12
Mexico City 12
Orem 12
Tokyo 12
Ankara 11
Da Nang 11
Guangzhou 11
Johannesburg 11
Stockholm 11
Tashkent 11
Brno 10
Chennai 10
Council Bluffs 10
Norwalk 10
Poplar 10
San Francisco 10
Toronto 10
Baghdad 9
Guarulhos 9
Tianjin 9
Biên Hòa 8
Haiphong 8
Kilburn 8
Kunming 8
Redmond 8
Campinas 7
Miami 7
Nova Iguaçu 7
Oxford 7
Quito 7
Salvador 7
Turin 7
Wuhan 7
Asunción 6
Canoas 6
Delhi 6
Salt Lake City 6
Santo André 6
Totale 69.495
Salva come PNG Salva come JPEG
Nome #
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 2.057
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors 2.047
Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history 1.876
Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease 1.607
RORGT-expressing tregs drive the growth of colitis-associated colorectal cancer by controlling IL6 in dendritic cells 1.554
Response Assessed by Ultrasonography as Target of Biological Treatment for Crohn's Disease 1.546
The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective 1.501
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease 1.305
A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn's disease 1.293
Outcomes of COVID-19 in 79 patients with IBD in Italy: An IG-IBD study 1.260
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study 1.243
Multidimensional Impact of Mediterranean Diet on IBD Patients 1.225
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 1.175
Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis 1.135
Quercetin and its derivates as antiviral potentials: A comprehensive review 1.098
Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases 1.090
Reciprocal regulation between Smad7 and Sirt1 in the gut 1.032
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide 1.009
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 1.009
The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation 991
Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down? 970
Tumor infiltrating regulatory t cells in sporadic and colitis-associated colorectal cancer: The red little riding hood and the wolf 969
Heligmosomoides polygyrus bakeri infection decreases Smad7 expression in intestinal CD4+ T cells, which allows TGF-b to induce IL-10–producing regulatory T cells that block colitis 960
Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaign 929
GPR120/FFAR4: A Potential New Therapeutic Target for Inflammatory Bowel Disease 906
Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death 901
Advanced imaging and Crohn's disease: An overview of clinical application and the added value of artificial intelligence 885
Activation of TGF-β-induced non-Smad signaling pathways during Th17 differentiation 855
A functional role for Smad7 in sustaining colon cancer cell growth and survival 841
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth 841
A Pharmacological Batch of Mongersen that Downregulates Smad7 is Effective as Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study 798
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 777
Smad7 in intestinal CD4+ T cells determines autoimmunity in a spontaneous model of multiple sclerosis 737
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages 732
Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease 675
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 674
Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis 673
Immune system and gut microbiota senescence in elderly IBD patients 669
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells 661
2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression 640
Smad7 expression in T cells prevents colitis-associated cancer 633
null 617
Reprogramming the immune system in IBD 604
The impact of translational research on gastroenterology 604
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 591
Seroprevalence of SARS-CoV2 in IBD patients treated with biologic therapy 557
From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies 555
Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression 534
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine 528
Defining Comprehensive Disease Control for use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations 521
Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies 516
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer 513
Intestinal inflammation and colorectal cancer: a double-edged sword? 496
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 489
Clinical and epidemiological features of ulcerative colitis patients in Sardinia, Italy: Results from a multicenter study 483
Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases 482
The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6 478
Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via a p38 Map kinase-dependent induction of SOCS-3 475
High resolution colonoscopy in live mice 463
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 463
Regulation of homeostasis and inflammation in the intestine 462
Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase 457
Drug insight: novel small molecules and drugs for immunosuppression 447
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid 447
Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis 443
Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut 441
Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferation 440
Timing of proper introduction, optimization and maintenance of anti-TNF therapy in IBD: Results from a Delphi consensus 439
Inhibitory Effect of Quercetin on Oxidative Endogen Enzymes: A Focus on Putative Binding Modes 439
Diagnostic delay in adult coeliac disease: An Italian multicentre study 436
New players in the cytokine orchestra of inflammatory bowel disease 434
Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis 426
Spatiotemporal patterns of expression of neurotrophins and neurotrophin receptors in mice suggest functional roles in testicular and epididymal morphogenesis 420
IL10 Secretion Endows Intestinal Human iNKT Cells with Regulatory Functions Towards Pathogenic T Lymphocytes 408
IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1 407
A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells 405
In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy 401
Multiple Orocutaneous Extraintestinal Manifestations in Ulcerative Colitis Patient: Complete Response to Ustekinumab 400
IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa 399
Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review 389
Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel disease 389
Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 387
TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling 384
IL-21 comes of age as a regulator of effector T cells in the gut 383
IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes 378
Cytokines: from gut inflammation to colorectal cancer 376
In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells 374
Regulation of gut inflammation and th17 cell response by interleukin-21 373
Angiogenesis, immune system and growth factors: new targets in colorectal cancer therapy 372
TGF-beta as a T cell regulator in colitis and colon cancer 371
Role of interleukin-21 in inflammation and allergy 367
Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells 365
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease 358
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 358
Fecal alpha 1-antitrypsin clearance as a marker of clinical relapse in patients with Crohn's disease of the distal ileum 356
Telemedicine and remote screening for COVID-19 in inflammatory bowel disease patients: results from the SoCOVID-19 survey 351
IL-6 signaling promotes tumor growth in colorectal cancer 349
EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation 346
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 342
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology 330
Totale 69.597
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.665
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.124 0 0 0 0 0 1.125 762 650 179 386 369 653
2021/20225.699 362 462 288 255 479 473 250 494 442 691 871 632
2022/20239.989 797 1.203 1.202 524 662 1.418 640 939 577 649 811 567
2023/202412.823 522 435 373 894 1.421 2.156 2.253 819 617 811 1.347 1.175
2024/202525.121 5.286 6.813 3.029 3.188 1.712 1.709 2.055 105 394 334 230 266
2025/20264.108 455 283 988 1.174 579 629 0 0 0 0 0 0
Totale 73.121